Novo Nordisk
NVO
#109
Rank
HK$1.414 T
Marketcap
HK$320.81
Share price
0.48%
Change (1 day)
-10.16%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): HK$22.36

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is HK$30.95. In 2022 the company made an earnings per share (EPS) of HK$17.03 an increase over its 2021 EPS that were of HK$15.62.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$22.3631.35%
2022HK$17.039.01%
2021HK$15.6215.08%
2020HK$13.5714.83%
2019HK$11.82-1.68%
2018HK$12.024.96%
2017HK$11.4531.08%
2016HK$8.74-10.33%
2015HK$9.7413.91%
2014HK$8.554.03%
2013HK$8.22-28.81%
2012HK$11.55108.9%
2011HK$5.5325.59%
2010HK$4.4035.01%
2009HK$3.26-9.17%
2008HK$3.5961.35%
2007HK$2.2228.96%
2006HK$1.7325.63%
2005HK$1.374.17%
2004HK$1.3213.55%
2003HK$1.1636.87%
2002HK$0.85-6.99%
2001HK$0.9121.56%
2000HK$0.7549.45%
1999HK$0.503.78%
1998HK$0.4812.15%
1997HK$0.4324.74%
1996HK$0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.33 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.46 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA